Sun 22 Nov 2009 | 19:53 EST
You are here: Home > Business & Finance > Stocks > Overview > Company Profile
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Company Profile
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Full Description

AstraZeneca PLC (AZN.L) (London Stock Exchange)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View AZN on other exchanges
As of  20 Nov 2009
2,695.00GBp
Price Change
-11.50
Percent Change
-0.42%
 
Research Another Stock: Symbol Look-up

 
Back to the Company Overview
AstraZeneca PLC is a United Kingdom-based pharmaceutical company, which discovers, develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for areas of healthcare, such as cardiovascular, gastrointestinal, infection, neuroscience, oncology, respiratory and inflammation. Its product range includes Arimidex, Crestor, Nexium, Seroquel and Symbicort. The Company has 26 manufacturing sites in 18 countries. On October 10, 2007, the Company’s subsidiary, Astra Tech, acquired Atlantis Components Inc. Astra Tech is engaged in the research, development, manufacture and marketing of medical devices and implants for use in healthcare, primarily in urology, surgery and odontology.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.